Amy Chang is bringing her years as a beauty creator and aesthetics consumer into a new venture.

She’s unveiling Matera, a 2,000-square-foot medical aesthetics practice in Santa Monica, Calif., built around what she calls “slow beauty.” It’s an approach centered on conservative treatment plans, longer consultations and removing sales incentives from the provider-patient relationship.

“I personally think that incentives drive behavior, and so, if it’s structured in a way where it’s encouraging people to upsell, then you get situations where people are receiving treatment that they don’t necessarily need,” Chang said.

Unlike many medspas, Matera won’t compensate providers through commission. Instead, Chang said its providers are paid 20 to 25 percent above market rates regardless of treatment volume.

The concept draws from more than 15 years of her own aesthetic treatments, she explained, as well as experiences visiting clinics in the U.S., Korea and Japan.

“I am that consumer,” she said.

Through the years, she’s been candidly sharing her experiences with her social media followers; she counts 1.6 million on TikTok and about 623,000 on Instagram. She also has an audience with her beauty podcast, “Mirror Mirror With Amy Chang.”

The business is entirely self-funded, Chang said, with no outside capital. Matera expects its first location to generate seven figures in revenue in its first year, with room to grow by adding providers before the company evaluates additional locations.

Patients will pay a premium for the model. Botox is priced at $20 a unit, while an initial consultation costs $400 and can be applied toward treatment within a specified period. Consultations incorporate detailed photography, 3D imaging and measurements intended to track changes over time.

“We definitely have to prove that it can be a successful financial model,” Chang said. “But just because it hasn’t been done this way before doesn’t mean that it can’t be successful.”

Chang partnered with Beverly Hills board-certified facial plastic surgeon and ENT specialist Dr. John Frederick, who serves as Matera’s medical director. The team also includes a physician assistant with experience across ICU neurosurgery, dermatology and aesthetics, an office manager and receptionist.

“What stood out to me about Matera is that it’s focused on achieving better outcomes — not selling more syringes,” Frederick said in a statement. “That emphasis on trust over volume is what makes this model meaningfully different.”

The five-treatment-room practice will offer neuromodulators, biostimulators, hyaluronic acid filler and energy-based treatments, while avoiding procedures Chang and Frederick consider to carry unnecessary risk. The practice also plans to invest in continuing education, including advanced trainings and international learning opportunities for providers.

Looking ahead, Chang said Matera could potentially remain a small boutique business.

“I could see it as maybe we just have one or two [locations], and we just lean into trust,” she said. “Or it could just be that we have this one very successful clinic, and I would be thrilled at that.”